Patient Provider Communication and Interaction in a Virtual Clinical Setting

Sponsor
National Human Genome Research Institute (NHGRI) (NIH)
Overall Status
Completed
CT.gov ID
NCT00669188
Collaborator
(none)
326
1
2
146.5
2.2

Study Details

Study Description

Brief Summary

Summary:

A few studies have explored factors which influence patient-provider communication in a controlled setting. However, more information is needed about how different factors affect communication so that it can be improved.

Third- and fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

At the research center, participants will use a virtual reality headset to view a virtual clinic environment and interact with a virtual patient.

After interacting with the virtual patient, participants will complete a questionnaire about their experience within the virtual clinic and other research-related information.

The total time for the study visit is 60 minutes.

Eligibility:

Third- and fourth-year medical students at least 18 years of age. You may not take part in the study if you have a history of seizures and/or are pregnant.

...

Condition or Disease Intervention/Treatment Phase
  • Other: Information absent
  • Other: Information
N/A

Detailed Description

This study will investigate research questions regarding factors influencing patient-provider communication. Participants will interact with a virtual patient in a virtual clinical setting.

Third- or fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

Study participants will perform one task and complete one set of questions at the study appointment. The task involves viewing a virtual patient s health information and interacting with the virtual patient in a virtual environment clinical scenario. While in the virtual environment, the subject wears a head-mounted video unit that allows him or her to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.

Study Design

Study Type:
Interventional
Actual Enrollment :
326 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Patient-Provider Communication and Interaction in a Virtual Clinical Setting
Actual Study Start Date :
Apr 24, 2008
Actual Primary Completion Date :
Jul 8, 2020
Actual Study Completion Date :
Jul 8, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Information Type 1

genetic risk information

Other: Information
Information

Sham Comparator: Information Type 2

information absent

Other: Information absent
Information

Outcome Measures

Primary Outcome Measures

  1. treatment recommendations [at time of study]

    recommendations made for the virtual patient's treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
  • INCLUSION CRITERIA:

Healthy adult volunteers who are third or fourth-year medical students. Both men and women over age 18 will be eligible for this study (though in practice the age range is likely to naturally be constrained by the typical age of medical students).

EXCLUSION CRITERIA: 1) persons with seizure or vestibular disorders; 2) women with known pregnancy; 3) persons who are highly prone to motion sickness; 4) those with low, uncorrected vision or hearing; 5) all current and past employees and contractors of

NHGRI; and 6) persons who have received information about the study purpose or procedure from a past participant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institutes of Health Clinical Center Bethesda Maryland United States 20892

Sponsors and Collaborators

  • National Human Genome Research Institute (NHGRI)

Investigators

  • Principal Investigator: Susan Persky, Ph.D., National Human Genome Research Institute (NHGRI)

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
National Human Genome Research Institute (NHGRI)
ClinicalTrials.gov Identifier:
NCT00669188
Other Study ID Numbers:
  • 080122
  • 08-HG-0122
First Posted:
Apr 30, 2008
Last Update Posted:
Aug 25, 2022
Last Verified:
Jul 28, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Human Genome Research Institute (NHGRI)

Study Results

No Results Posted as of Aug 25, 2022